Bengsch, Knoblock [87] demonstrated that targeting CD25, using an anti-CD25 antibody in PDAC, reduced the number of Treg cells within the tumour and increased the number of CD4+ T helper cells, reaffirming that depleting Tregs revitalises the immune system for an anti-tumour immune response. This evidence concerns the gene CD4 and neoplasm.